+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Boronic Acids 787591-39-3
787591-39-3,MFCD04440857
Catalog No.:AA005PH1

787591-39-3 | N-[2-(morpholin-4-yl)ethyl]-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
97%
in stock  
$87.00   $61.00
- +
1g
97%
in stock  
$168.00   $117.00
- +
5g
97%
in stock  
$720.00   $504.00
- +
10g
97%
in stock  
$1,427.00   $999.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA005PH1
Chemical Name:
N-[2-(morpholin-4-yl)ethyl]-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
CAS Number:
787591-39-3
Molecular Formula:
C19H29BN2O4
Molecular Weight:
360.2556
MDL Number:
MFCD04440857
SMILES:
O=C(c1ccc(cc1)B1OC(C(O1)(C)C)(C)C)NCCN1CCOCC1
Properties
Properties
 
Form:
Solid  

Computed Properties
 
Complexity:
470  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
5  

Downstream Synthesis Route
787591-39-3    117718-82-8   
4-(8-methylamino-imidazo1,2-apyrazin-3-yl)-N-(2-morpholin-4-yl-ethyl)-benzamide 

[1]CurrentPatentAssignee:PFIZERINC-US2004/220189,2004,A1Locationinpatent:Page45-46

[1]CurrentPatentAssignee:PFIZERINC-US2004/220189,2004,A1Locationinpatent:Page45-46

[2]Locationinpatent:schemeortableTrujillo,JohnI.;Kiefer,JamesR.;Huang,Wei;Day,JacquelineE.;Moon,Joseph;Jerome,GinaM.;Bono,ChristineP.;Kornmeier,ChristineM.;Williams,MelanieL.;Kuhn,Cyrille;Rennie,GlenR.;Wynn,ThomasA.;Carron,ChristopherP.;Thorarensen,Atli[BioorganicandMedicinalChemistryLetters,2012,vol.22,#11,p.3795-3799]

[1]Locationinpatent:schemeortableTrujillo,JohnI.;Kiefer,JamesR.;Huang,Wei;Day,JacquelineE.;Moon,Joseph;Jerome,GinaM.;Bono,ChristineP.;Kornmeier,ChristineM.;Williams,MelanieL.;Kuhn,Cyrille;Rennie,GlenR.;Wynn,ThomasA.;Carron,ChristopherP.;Thorarensen,Atli[BioorganicandMedicinalChemistryLetters,2012,vol.22,#11,p.3795-3799]

[1]Locationinpatent:schemeortableTrujillo,JohnI.;Kiefer,JamesR.;Huang,Wei;Day,JacquelineE.;Moon,Joseph;Jerome,GinaM.;Bono,ChristineP.;Kornmeier,ChristineM.;Williams,MelanieL.;Kuhn,Cyrille;Rennie,GlenR.;Wynn,ThomasA.;Carron,ChristopherP.;Thorarensen,Atli[BioorganicandMedicinalChemistryLetters,2012,vol.22,#11,p.3795-3799]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 787591-39-3
656239-38-2

656239-38-2

 864754-07-4

864754-07-4

 832114-11-1

832114-11-1

 832114-06-4

832114-06-4

 1073353-60-2

1073353-60-2

 656239-39-3

656239-39-3
Building Blocks
More >
Tags:787591-39-3 Molecular Formula|787591-39-3 MDL|787591-39-3 SMILES|787591-39-3 N-[2-(morpholin-4-yl)ethyl]-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide